These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11180567)

  • 1. A comparison of scoring weights for the EuroQol derived from patients and the general public.
    Polsky D; Willke RJ; Scott K; Schulman KA; Glick HA
    Health Econ; 2001 Jan; 10(1):27-37. PubMed ID: 11180567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index.
    Glick HA; Polsky D; Willke RJ; Schulman KA
    Med Decis Making; 1999; 19(3):265-75. PubMed ID: 10424833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description and valuation of health-related quality of life among the general public in Japan by the EuroQol.
    Hisashige A; Mikasa H; Katayama T
    J Med Invest; 1998 Aug; 45(1-4):123-9. PubMed ID: 9864973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway.
    Nord E
    Health Policy; 1991 Jun; 18(1):25-36. PubMed ID: 10112299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The validity of a visual analogue scale in determining social utility weights for health states.
    Nord E
    Int J Health Plann Manage; 1991; 6(3):234-42. PubMed ID: 10116626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial.
    Dorman P; Slattery J; Farrell B; Dennis M; Sandercock P
    Stroke; 1998 Jan; 29(1):63-8. PubMed ID: 9445330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of the quality of life in rheumatic disorders using the EuroQol.
    Wolfe F; Hawley DJ
    Br J Rheumatol; 1997 Jul; 36(7):786-93. PubMed ID: 9255115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health state valuations from the general public using the visual analogue scale.
    Gudex C; Dolan P; Kind P; Williams A
    Qual Life Res; 1996 Dec; 5(6):521-31. PubMed ID: 8993098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling valuations for health states: the effect of duration.
    Dolan P
    Health Policy; 1996 Dec; 38(3):189-203. PubMed ID: 10162421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single European currency for EQ-5D health states. Results from a six-country study.
    Greiner W; Weijnen T; Nieuwenhuizen M; Oppe S; Badia X; Busschbach J; Buxton M; Dolan P; Kind P; Krabbe P; Ohinmaa A; Parkin D; Roset M; Sintonen H; Tsuchiya A; de Charro F
    Eur J Health Econ; 2003 Sep; 4(3):222-31. PubMed ID: 15609189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome.
    Myers C; Wilks D
    Qual Life Res; 1999; 8(1-2):9-16. PubMed ID: 10457734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valuations of EQ-5D health states: are the United States and United Kingdom different?
    Johnson JA; Luo N; Shaw JW; Kind P; Coons SJ
    Med Care; 2005 Mar; 43(3):221-8. PubMed ID: 15725978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling valuations for EuroQol health states.
    Dolan P
    Med Care; 1997 Nov; 35(11):1095-108. PubMed ID: 9366889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.